CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
REVENUES	$ 258,215	$ 154,080	$ 80,943
Cost of product revenue	169,273	118,815	79,770
Gross profit	88,942	35,265	1,173
OPERATING EXPENSES:
Research and development	3,300	3,614	3,646
Plasma center operating expenses	4,266	17,843	12,289
Amortization of intangible assets	724	715	715
Selling, general and administrative	59,020	52,458	42,897
Total operating expenses	67,310	74,630	59,547
INCOME (LOSS) FROM OPERATIONS	21,632	(39,365)	(58,374)
OTHER INCOME (EXPENSE):
Interest income	1,617	45	35
Interest expense	(25,027)	(19,279)	(13,057)
Loss on extinguishment of debt	(26,174)	(6,670)	0
Other expense	(287)	(635)	(252)
Other expense, net	(49,871)	(26,539)	(13,274)
NET LOSS	$ (28,239)	$ (65,904)	$ (71,648)
BASIC LOSS PER COMMON SHARE (in dollars per share)	$ (0.13)	$ (0.33)	$ (0.51)
DILUTED LOSS PER COMMON SHARE (in dollars per share)	$ (0.13)	$ (0.33)	$ (0.51)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)	223,977,315	197,874,895	139,578,538
Diluted (in shares)	223,977,315	197,874,895	139,578,538